HIGHLIGHTS
SUMMARY
The incidence and prevalence of CKD are increasing worldwide, along with the burdens of HT, diabetes_mellitus (DM), hyperlipidemia, obesity, smoking, and aging. Patients with CKD are at a high risk of progressing toward end-stage renal disease (ESRD) and early morbidity and mortality due to premature cardiovascular disease (CVD). Strategies for reducing the cardiovascular risk of CKD should be adopted in each country; however, there is an unmet need for further evaluation in clinical trials, particularly in patients with advanced CKD or ESRD. In the study, those with CKD had higher levels of SUR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.